Drug Database
Back to search

Switzerland· 29934010

Petinimid, Weichkapseln

A ethosuximide product containing ethosuximidum, registered in Switzerland by axapharm ag and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC N03AD01

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedPetinimid, WeichkapselnATCN03AD01REGISTER NO.29934010PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ethosuximidumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ethosuximide is registered in 16 of 19 countries.

Countries holding a registration under ATC N03AD01 (ethosuximide), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 8 of them publish a price we can compare per daily dose
Search ethosuximide products by name

Ethosuximide · ATC N03AD01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ethosuximide costs, country by country.

Normalised to the WHO defined daily dose (1.25 g), so markets compare like for like.

  • Switzerland: $1.83 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Ethosuximide · price per daily dose (1.25 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.83
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
ethosuximidum
Manufacturer
axapharm ag
Country
Switzerland (CH)
ATC code
N03AD01
ATC class
Ethosuximide
Defined daily dose
1.25 g, O
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680299340105
    100 Stk
    CHF 30.35

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

124 interactions on record for ethosuximide.

Graded by severity as the source publishes them — 124 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ethosuximide against other medicinesHow interaction checks work

Ethosuximide · interactions on record

124 records

  • 124 moderate

Most severe, free to view

  • MetoclopramideA03FA01moderate
  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate
  • DronabinolA04AD10moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ethosuximide in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ethosuximide products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Ethosuximid Neuraxpharm, Petinimid
  • Belgium · Zarontin
  • Bulgaria · Petinimid
  • Czechia · Petinimid
  • Germany · Ethosuximid Glenmark, Ethosuximid Neuraxpharm
  • Denmark · Ethosuximide Orifarm, Ethosuximide Strides
  • Spain · Etosuximida Faes
  • France · Zarontin
  • United Kingdom (Northern Ireland) · Emeside, Epesri
  • Croatia · Suxital
  • Ireland · Zarontin
  • Italy · Etosuccimide Glenmark, Zarontin
  • Luxembourg · Zarontin
  • Netherlands · Ethosuximide Aurobindo, Ethosuximide Strides
  • Norway · Ethosuximide Orifarm, Ethosuximide Strides
  • Poland · Petinimid
  • Sweden · Ethosuximide Orifarm, Ethosuximide Strides
  • Slovenia · Suxital
  • Slovakia · Petinimid Cps, Petnidan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cfde53e2-e6b2-4aa5-aa89-20b3cf9babb9
GET /v1/drugs/cfde53e2-e6b2-4aa5-aa89-20b3cf9babb9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "ethosuximidum 250 mg",
  "valid_from": "1977-03-15",
  "limitations": null,
  "galenic_form": "Kaps 250 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "1977-03-15",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about ethosuximide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console